Table 3 Laboratory and clinical markers—results of interest
From: Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function
Pre-treatment Regular Dialysis | Post-treatment SGLT-2 Dialysis | P-value* | |
|---|---|---|---|
Median [Range] | |||
D/P | 0.732 [0.596–0.921] | 0.767 [0.537–0.913] | 0.940 |
D4/D0 | 0.263 [0.165–0.384] | 0.290 [0.143–0.396] | 0.433 |
Sodium Dip | 6.5 [1.0–16.0] | 7.0 [3.0–16.0] | 0.587 |
Ultrafiltration | 715 [-500–1225] | 700 [320–1160] | 0.322 |
Weight | 77 [47.5–115] | 77.5 [44–112] | 0.087 |
Serum IL-6 | 5 [0–22.2] | 0 [0–18] | 0.084 |
Fluid VEGF | 9 [0–72.5] | 2.5 [0–127] | 0.349 |
Serum VEGF | 185 [60–475] | 210 [63–478] | 0.394 |